Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 356521 - 356540 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Norway | (L01FG01) bevacizumab | Aybintio 25 mg/ml | 1 x 16 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 25 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | SamsungBioepisNLB.V. |
| Norway | (L01FG01) bevacizumab | Aybintio 25 mg/ml | 1 x 4 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 25 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | SamsungBioepisNLB.V. |
| Norway | (L01FG01) bevacizumab | Zirabev 25 mg/ml | 1 x 4 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 25 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | PfizerEuropeMAEEIG |
| Norway | (L01FG01) bevacizumab | Zirabev 25 mg/ml | 1 x 16 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 25 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | PfizerEuropeMAEEIG |
| Norway | (L01FX04) ipilimumab | Yervoy 5 mg/ml | 1 x 10 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 5 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Mesothelioma, Malignant;Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG |
| Norway | (L01FX04) ipilimumab | Yervoy 5 mg/ml | 1 x 40 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 5 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Mesothelioma, Malignant;Colorectal Neoplasms | AbacusMedicineA/S |
| Norway | (L01FX04) ipilimumab | Yervoy 5 mg/ml | 1 x 40 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 5 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Mesothelioma, Malignant;Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG |
| Norway | (L01FX04) ipilimumab | Yervoy 5 mg/ml | 1 x 10 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 5 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Mesothelioma, Malignant;Colorectal Neoplasms | AbacusMedicineA/S |
| Norway | (L01FY01) pertuzumab and trastuzumab | Phesgo 1 200 mg/600 mg | 15 ml, Hetteglass, Injeksjonsvæske, oppløsning, 1 200 mg/600 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | OrifarmAS |
| Norway | (L01FY01) pertuzumab and trastuzumab | Phesgo 1 200 mg/600 mg | 15 ml, Hetteglass, Injeksjonsvæske, oppløsning, 1 200 mg/600 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH |
| Norway | (L01FY01) pertuzumab and trastuzumab | Phesgo 600 mg/600 mg | 10 ml, Hetteglass, Injeksjonsvæske, oppløsning, 600 mg/600 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH |
| Norway | (L01FY01) pertuzumab and trastuzumab | Phesgo 600 mg/600 mg | 10 ml, Hetteglass, Injeksjonsvæske, oppløsning, 600 mg/600 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | OrifarmAS |
| Norway | (L01XG02) carfilzomib | Kyprolis 10 mg | 10 mg, Hetteglass, Pulver til infusjonsvæske, oppløsning, 10 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | AmgenEuropeB.V. |
| Norway | (L01XG02) carfilzomib | Kyprolis 30 mg | 30 mg, Hetteglass, Pulver til infusjonsvæske, oppløsning, 30 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | AbacusMedicineA/S |
| Norway | (L01XG02) carfilzomib | Kyprolis 30 mg | 1 x 30 mg, Hetteglass, Pulver til infusjonsvæske, oppløsning, 30 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | OrifarmAS |
| Norway | (L01XG02) carfilzomib | Kyprolis 30 mg | 30 mg, Hetteglass, Pulver til infusjonsvæske, oppløsning, 30 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | AmgenEuropeB.V. |
| Norway | (L01XG02) carfilzomib | Kyprolis 60 mg | 1 x 60 mg, Hetteglass, Pulver til infusjonsvæske, oppløsning, 60 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | OrifarmAS |
| Norway | (L01XG02) carfilzomib | Kyprolis 60 mg | 60 mg, Hetteglass, Pulver til infusjonsvæske, oppløsning, 60 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | AbacusMedicineA/S |
| Norway | (L01XG02) carfilzomib | Kyprolis 60 mg | 60 mg, Hetteglass, Pulver til infusjonsvæske, oppløsning, 60 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | AmgenEuropeB.V. |
| Norway | (L01XK01) olaparib | Lynparza 100 mg | 56 stk, Blisterpakning, Tablett, filmdrasjert, 100 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Ovarian Neoplasms;Breast Neoplasms;Pancreatic Neoplasms;Prostatic Neoplasms, Castration-Resistant | AstraZenecaAB(2) |
Pages
